MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/09546634.2026.2660529

Медицинская библиотека · The Journal of dermatological treatment · 2026

Intralesional secukinumab for localized, recalcitrant hidradenitis suppurativa: a case series of rapid symptom relief.

Zheng Junyou, Luo Dong, Zhang Ke, Zhang Qian, Li Xiaofang, Fang Fang, Bu Wenbo, Hou Binbin

СтатьяКлинический случайПеревод в очереди

Аннотация

PURPOSE: Hidradenitis suppurativa (HS) is a debilitating, chronic, inflammatory disease. While secukinumab (an IL-17A inhibitor) demonstrates systemic efficacy, specific lesions often remain resistant to systemic therapy, representing a significant unmet clinical need. This case series aimed to evaluate the efficacy and safety of intralesional secukinumab for localized HS lesions.

MATERIALS AND

METHODS

We retrospectively analyzed five patients treated with this modality after failing conventional therapies, including oral tetracyclines and oral/intralesional corticosteroids.

RESULTS

Post-treatment, all targeted lesions showed marked reduction in inflammation and nodule size. Notably, patient-reported Visual Analogue Scale (VAS) and Dermatology Life Quality Index (DLQI) scores decreased rapidly in the short term. No severe local adverse events or systemic side effects were observed.

CONCLUSIONS

These preliminary findings suggest that intralesional secukinumab may serve as an effective, well-tolerated adjunctive strategy, particularly for localized, recalcitrant lesions, offering a new perspective in HS management.

Для цитирования: Zheng Junyou, Luo Dong, Zhang Ke, Zhang Qian, Li Xiaofang, Fang Fang, Bu Wenbo, Hou Binbin. Intralesional secukinumab for localized, recalcitrant hidradenitis suppurativa: a case series of rapid symptom relief.. The Journal of dermatological treatment. 2026. DOI: 10.1080/09546634.2026.2660529.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.